Current Studies

Click on a study for more information
Alzheimer's Disease (click here)

We are currently enrolling in studies for Alzheimer’s Disease.

Acumen_ACU193-201

Experiencing Memory Problems? Memory loss is more common than any of us would like to admit—and experiencing memory problems or watching someone you love experience memory problems can be challenging. By participating in a clinical trial, you or your loved one can help to advance Alzheimer’s treatment, helping scientists better understand if a new investigational treatment might be beneficial.

For more information or to sign up, click here.

Cassava_PTI-125-10

Study to evaluate the safety and tolerability of simufilam 100 mg tablets in participants with mild to moderate Alzheimer’s disease

Study Details | Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer’s Disease | ClinicalTrials.gov

For more information or to sign up, click here.

Eli Lilly_J1G-MC-LAKC

Assessment of safety and efficacy measured by amyloid reduction of remternetug in early symptomatic Alzheimer’s disease

Study Details | A Study of Remternetug (LY3372993) in Participants With Alzheimer’s Disease (TRAILRUNNER-ALZ 1) | ClinicalTrials.gov

For more information or to sign up, click here.

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Click Here)

We are currently enrolling in studies for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Immunovant_IMVT-1401-2401

Study of batoclimab treatment in adult participants with active chronic inflammatory demyelinating polyneuropathy (CIDP)

Study Details | To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP | ClinicalTrials.gov

For more information or to sign up, click here.

Migraine (Click Here)

We are currently enrolling in studies for Migraine.

Abbvie_M22-418

Study to evaluate the safety, tolerability, and efficacy of atogepant when added to BOTOX for the preventive treatment of chronic migraine

Study Details | Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine | ClinicalTrials.gov

For more information or to sign up, click here.

Lundbeck_20297A

The PROCEED Trial is evaluating the effectiveness of an investigational trial drug for the prevention of migraine.

Study Details | A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments | ClinicalTrials.gov

For more information or to sign up, click here.

Myasthenia Gravis (click here)

We are currently enrolling in studies for Myasthenia Gravis.

NMD Pharma_NMD670-02-002

For those with myasthenia gravis…No moment feels small. Every movement feels big. And new research feels tremendous. Click to learn more about the SYNAPSE-MG study, sponsored by NMD Pharma, for adults with myasthenia gravis.

Study Details | Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis | ClinicalTrials.gov

For more information or to sign up, click here.

Multiple Sclerosis (click here)

We are currently enrolling in studies for Multiple Sclerosis.

Sanofi_EFC17919

Seeking participants with relapsing multiple sclerosis (RMS) for clinical trial

Study Details | Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis | ClinicalTrials.gov

For more information or to sign up, click here.

Sanofi_EFC17504

Seeking participants with non-relapsing secondary progressive multiple sclerosis (nrSPMS).

Study Details | Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis | ClinicalTrials.gov

For more information or to sign up, click here.

Neurodegenerative Diseases (Click Here)

We are currently enrolling in studies for Neurodegenerative Diseases.

BioSpyder_2020/09/14

TempO-seq whole blood assay for evaluation of progression and outcome in neurodegenerative and other diseases

For more information or to sign up, click here.

Progressive Supranuclear Palsy (Click Here)

We are currently enrolling in studies for Progressive Supranuclear Palsy.

Ferrer Internacional, S.A._FNP223-CT-2301

You or someone you care for could be eligible to take part in a research study for people who have been diagnosed with Progressive Supranuclear Palsy (PSP) Richardson Syndrome subtype. This study is testing the safety and effectiveness of an investigational drug for people living with PSP.

Study Details | A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) | ClinicalTrials.gov

For more information or to sign up, click here.

Thyroid Eye Disease (Click Here)

We are currently enrolling in studies for Thyroid Eye Disease.

Immunovant_IMVT-1401-3201

Dealing with Thyroid Eye Disease? Learn about the GO-1 Research Study for adults diagnosed with thyroid eye disease (TED).

Study Details | Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease | ClinicalTrials.gov

For more information or to sign up, click here.

Immunovant_IMVT-1401-3203

Dealing with Thyroid Eye Disease? Learn about the GO-1 Research Study for adults diagnosed with thyroid eye disease (TED).

Study Details | Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease | ClinicalTrials.gov

For more information or to sign up, click here.

Current Areas of Research

Alzheimer's Disease/Dementia
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Migraine
Myasthenia Gravis (MG)
Multiple Sclerosis (MS)
Neurodegenerative Diseases
Progressive Supranuclear Palsy
Thyroid Eye Disease

Menu